CMAJ • April 8, 2008; 178 (8). doi:10.1503/cmaj.070426.
© 2008 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Résumé
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klomp, H.
Right arrow Articles by Jorgenson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klomp, H., RN MSc
Right arrow Articles by Jorgenson, D., PharmD
Related Collections
Right arrow Asthma
Right arrowRelated Articles

Examining asthma quality of care using a population-based approach

Helena Klomp, RN MSc, Joshua A. Lawson, MSc, Donald W. Cockcroft, MD, Benjamin T. Chan, MD MPH, Paul Cascagnette, BSc, Laurie Gander, RN MN and Derek Jorgenson, PharmD

From the Health Quality Council (Klomp, Cascagnette, Gander), Saskatoon, Sask.; the Canadian Centre for Health and Safety in Agriculture (Lawson), University of Saskatchewan; the Department of Medicine (Cockcroft), University of Saskatchewan, Saskatoon, Sask.; the Ontario Health Quality Council (Chan), Toronto, Ont.; the Department of Pharmaceutical Services (Jorgenson), Saskatoon Health Region, Saskatoon, Sask.


View this table:
[in this window]
[in a new window]

  		Table 1.

 

View this table:
[in this window]
[in a new window]

  		Table 2.

 

View this table:
[in this window]
[in a new window]

  		Table 3.

 

Figure 117
View larger version (25K):
[in this window]
[in a new window]

  		Figure 1: Prevalence of asthma in Saskatchewan by age and sex in 2002/03. *Significant difference (p < 0.05) between males and females.

 

Figure 217
View larger version (17K):
[in this window]
[in a new window]

  		Figure 2: Rates of hospital admission because of asthma among people with asthma in Saskatchewan in 2003/04. *Significant difference (p < 0.05) between males and females.

 

View this table:
[in this window]
[in a new window]

  		Table 4.

 

Figure 317
View larger version (30K):
[in this window]
[in a new window]

  		Figure 3: Rates of asthma quality-of-care indicators in Saskatchewan in 2003/04. All rates, except crude overall rates, were adjusted using the indicator denominator population (Table 1). Residents with registered Indian status were excluded from our study. Of the cases identified in 2002/03 (26 616), 24 180 were eligible for inclusion in 2003/04. *Adjusted for sex. {dagger}Adjusted for age. {ddagger}Adjusted for age and sex. §Significantly different (p < 0.05) from the rate across all other categories within the variable group. ¶At least moderate inhaled corticosteroid use was defined as ≥ 251 µg/d for fluticasone and beclomethasone-HFA, ≥ 501 µg/d for beclomethasone-CFC and budesonide nebulizer solution, ≥ 1001 µg/d for beclomethasone dry powder inhaler, ≥ 401 µg/d for budesonide inhaler. Note: CI = confidence interval, NR = not reported (owing to a sample size of less than 6).